OVERVIEW

Live Virtual Symposium: @MondayNightIBD LIVE: Addressing the Cases That Challenge Your Practice is organized by CME Outfitters, LLC.

Premiere Date: Monday, May 4, 2020
Credit Expiration Date: Tuesday, May 4, 2021

This activity offers CE credit for:
• Physicians (CME)
• Nurses (CNE)
• Pharmacists (ACPE)
• ABIM (MOC)
• Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Information:
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.

Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

CPE Credit (Pharmacists):
ACPECME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs).

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Note to PAs: PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Statement of Need:
Gastroenterologists are trailblazers in health care social media, and @MondayNightIBD has harnessed that energy to establish gastroenterologists as not just social media influencers but as clinical practice influencers as well. @MondayNightIBD is not just a weekly social media conversation – it is an international platform that is moving the field forward by crowdsourcing the expertise of leading inflammatory bowel disease (IBD) experts, community clinicians, and patients to meet the many challenges of IBD.

CME Outfitters is partnering with @MondayNightIBD to bring its founder Dr. Aline Charabaty’s hugely successful endeavor to learners via a live virtual symposium. True to the social media format, a panel of experts will discuss a series of patient cases and integrate onsite and Twitter polling with the goal of helping clinicians better understand, share, and implement optimal management strategies for IBD.

Learning Objectives:
At the end of this CE activity, participants should be able to:
• Apply efficacy, safety, and comparative effectiveness data for existing and emerging therapies to optimize therapy selection for patients with IBD.
• Identify appropriate treatment strategies for special populations with IBD such as pregnant/lactating women, the elderly, and patients with Clostridioides difficile infection (CDI).
• Develop strategies, such as disease monitoring, therapeutic drug monitoring (TDM), shared decision-making (SDM), and patient education, to achieve optimal patient outcomes.
The following learning objectives pertain only to those requesting CNE or CPE credit:
• Explain efficacy, safety, and comparative effectiveness data for existing and emerging therapies to optimize therapy selection for patients with IBD.
• Identify appropriate treatment strategies for special populations with IBD such as pregnant/lactating women, the elderly, and patients with CDI.
• Describe strategies, such as disease monitoring, therapeutic drug monitoring (TDM), shared decision-making (SDM), and patient education, to achieve optimal patient outcomes.